Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis
Aim: To systematically compare the efficacy and safety of biologics [tumor necrosis factor inhibitors (TNFi), interleukin (IL) inhibitors, phosphodiesterase-4 inhibitors (PDE4i), and Janus kinase inhibitors (JAKi)] for biological-naïve patients with psoriatic arthritis (PsA).Methods: PubMed, Web of...
Saved in:
Main Authors: | Jixia Lin (Author), Yougang Ren (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis
by: Szu-Hsuan Wang, et al.
Published: (2022) -
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
by: Dafna D. Gladman, MD, et al.
Published: (2020) -
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS
by: D.D. Gladman
Published: (2011) -
The incidence of opportunistic infections in patients with psoriatic arthritis treated with biologic and targeted synthetic agents: A systematic review and meta-analysis
by: Athanasios Vassilopoulos, et al.
Published: (2022) -
Psoriatic arthritis: treatment strategies using biologic agents
by: C. Palazzi, et al.
Published: (2012)